Search research articles
Contact Us
Filters
Showing results (51-60 of 160) with videos related to
Page
of 16
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1996
Candida infection of the arteriovenous fistula used for hemodialysis
M H Nguyen, V L Yu, A J Morris
Chemical Reviews
|
May 3, 2023
Late-Stage C-H Functionalization of Azines
Celena M Josephitis, Hillary M H Nguyen, Andrew McNally
Nature
|
December 14, 2001
Himalayan tectonics explained by extrusion of a low-viscosity crustal channel coupled to focused surface denudation
C Beaumont, R A Jamieson, M H Nguyen, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply
D Lin, H-I Yang, J Hoang, et al.
Alimentary Pharmacology & Therapeutics
|
April 3, 2014
Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply
L Gao, H N Trinh, J Li, et al.
Alimentary Pharmacology & Therapeutics
|
January 29, 2014
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA
L Gao, H N Trinh, J Li, et al.
Metabolism: Clinical and Experimental
|
January 1, 1986
Effect of physical training on norepinephrine turnover in tissues of normal and diabetic rats
A Nadeau, G Tancrède, M H Nguyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 10, 1998
Subcutaneous abscesses due to Mycobacterium tuberculosis: paradoxical expansion of disease during therapy for miliary tuberculosis
J Berg, A Leonard, C J Clancy, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply
D Lin, H-I Yang, J Hoang, et al.
Alimentary Pharmacology & Therapeutics
|
May 8, 2014
Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply
L Gao, H N Trinh, J Li, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 160) with videos related to
Sort By:
Page
of 16
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1996
Candida infection of the arteriovenous fistula used for hemodialysis
M H Nguyen, V L Yu, A J Morris
Chemical Reviews
|
May 3, 2023
Late-Stage C-H Functionalization of Azines
Celena M Josephitis, Hillary M H Nguyen, Andrew McNally
Nature
|
December 14, 2001
Himalayan tectonics explained by extrusion of a low-viscosity crustal channel coupled to focused surface denudation
C Beaumont, R A Jamieson, M H Nguyen, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply
D Lin, H-I Yang, J Hoang, et al.
Alimentary Pharmacology & Therapeutics
|
April 3, 2014
Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply
L Gao, H N Trinh, J Li, et al.
Alimentary Pharmacology & Therapeutics
|
January 29, 2014
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA
L Gao, H N Trinh, J Li, et al.
Metabolism: Clinical and Experimental
|
January 1, 1986
Effect of physical training on norepinephrine turnover in tissues of normal and diabetic rats
A Nadeau, G Tancrède, M H Nguyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 10, 1998
Subcutaneous abscesses due to Mycobacterium tuberculosis: paradoxical expansion of disease during therapy for miliary tuberculosis
J Berg, A Leonard, C J Clancy, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply
D Lin, H-I Yang, J Hoang, et al.
Alimentary Pharmacology & Therapeutics
|
May 8, 2014
Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply
L Gao, H N Trinh, J Li, et al.
Page
of 16